Combination of ceftizoxime with azlocillin, mezlocillin, piperacillin and ticarcillin
Harold C. Neu
Abstract
Harold C. Neu
Abstract
Combination of two β -lactam agents has been used to enlarge the antibacterial spectrum of both the penicillin and cephalosporin components of the combination. However, some β-lactamase-stable cephalosporins by virtue of their induction of β-lactamases, cause destruction of the penicillins. Combination of ceftizoxime with azlocillin, meziocillin, piperacillin and ticarcillin showed synergy for 6.5–12%, an additive action for 9.8–25% and antagonism for only 1–3% of the 92 Enterobacteriaceae and Pseudomonas isolates tested. In contrast, combination of cefoxitin with the penicillins showed antagonism against 4–18% of isolates. Combination of ceftizoxime and oral antipseudomonas penicillins did not render strains resistant to the antipseudomonas penicillins susceptible. In no instance did the combination of ceftizoxime with an antipseudomonas penicillin cause an increase in minimal inhibitory concentration that would make the antagonism clinically significant.
OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Combination of two β -lactam agents has been used to enlarge the antibacterial spectrum of both the penicillin and cephalosporin components of the combination. However, some β-lactamase-stable cephalosporins by virtue of their induction of β-lactamases, cause destruction of the penicillins. Combination of ceftizoxime with azlocillin, meziocillin, piperacillin and ticarcillin showed synergy for 6.5–12%, an additive action for 9.8–25% and antagonism for only 1–3% of the 92 Enterobacteriaceae and Pseudomonas isolates tested. In contrast, combination of cefoxitin with the penicillins showed antagonism against 4–18% of isolates. Combination of ceftizoxime and oral antipseudomonas penicillins did not render strains resistant to the antipseudomonas penicillins susceptible. In no instance did the combination of ceftizoxime with an antipseudomonas penicillin cause an increase in minimal inhibitory concentration that would make the antagonism clinically significant.
Key concepts: Mezlocillin, Azlocillin, Ceftizoxime, Piperacillin, Ticarcillin, Medicine, Lomefloxacin, Cephalosporin